Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
Status:
Completed
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
Vancomycin is the most commonly used empiric treatment for infectious peritonitis in patients
on peritoneal dialysis. Current dosing and monitoring for safety and efficacy is empiric,
especially for those on rapid-cycling modalities. The goal of this study is to understand the
pharmacokinetics of vancomycin in patients on rapid-cycling peritoneal dialysis modalities in
order to derive an optimal dosing regimen.